Elevance Health President and CEO Gail Boudreaux earned $22.6 million in 2025, up from $20.5 million in 2024.
The company disclosed compensation data for its highest-paid executives in its annual proxy report published March 27.
Here’s what Elevance’s top executives earned in 2025:
Gail Boudreaux, president and CEO
Salary: $1,600,000
Stock awards: $13,440,277
Option awards: $4,199,765
Non-equity incentive plan compensation: $2,788,000
Other compensation: $574,272
Total compensation: $22,582,314
Mark Kaye, EVP and CFO
Salary: $938,462
Stock awards: $4,560,511
Option awards: $1,424,506
Non-equity incentive plan compensation: $974,123
Other compensation: $94,475
Total compensation: $7,092,077
Peter Haytaian, EVP and president, Carelon and CarelonRx
Salary: $950,000
Stock awards: $3,840,306
Option awards: $1,199,710
Non-equity incentive plan compensation: $986,100
Other compensation: $122,372
Total compensation: $7,096,488
Felicia Norwood, EVP and chief health benefits officer
Salary: $950,000
Stock awards: $3,840,306
Option awards: $1,199,710
Non-equity incentive plan compensation: $986,100
Other compensation: $97,840
Total compensation: $7,073,965
Morgan Kendrick, EVP and president, commercial and specialty health benefits
Salary: $888,462
Stock awards: $3,600,237
Option awards: $1,124,813
Non-equity incentive plan compensation: $922,223
Change in pension value and nonqualified deferred compensation earnings: $23,417
Other compensation: $102,759
Total compensation: $6,661,911
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
